Halsbev 400 mg/16 ml Injection
In stock
Description
Halsbev 400 Injection (bevacizumab) is a targeted cancer therapy that acts as an angiogenesis inhibitor, meaning it helps stop the growth of blood vessels that supply tumors with nutrients and oxygen. It is a monoclonal antibody used to treat various advanced or metastatic cancers.
Specifications
| Strength | 400 mg/16 ml |
|---|---|
| Main Ingredients | Bevacizumab |
| Uses | Cancer by inhibiting angiogenesis |
| Pack size | 16 ml |
| Pack type | Box |
| Shelf life | 24months |
